- Home
- EDIT vs EM Comparison
EDIT vs EM Comparison
Compare EDIT & EM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDIT | EM |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.8M | 296.7M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EDIT | EM |
|---|---|---|
| Price | $3.02 | $1.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $5.30 | $1.25 |
| AVG Volume (30 Days) | ★ 2.9M | 1.3M |
| Earning Date | 05-11-2026 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $31,937,000.00 | N/A |
| Revenue This Year | N/A | $3.30 |
| Revenue Next Year | N/A | $5.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $1.66 | $1.01 |
| 52 Week High | $4.54 | $1.46 |
Technical Indicators
Market Signals| Indicator | EDIT | EM |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 66.07 |
| Support Level | $2.42 | $1.16 |
| Resistance Level | $3.27 | $1.42 |
| Average True Range (ATR) | 0.34 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 39.33 | 73.68 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.